Your browser doesn't support javascript.
loading
Association between post-percutaneous coronary intervention bivalirudin infusion and net adverse clinical events: a post hoc analysis of the GLOBAL LEADERS study.
Chang, Chun Chin; Chichareon, Ply; Modolo, Rodrigo; Takahashi, Kuniaki; Kogame, Norihiro; Tomaniak, Mariusz; Gao, Chao; Royaards, Kees-Jan; Cequier, Angel; Oldroyd, Keith; Steg, Philippe Gabriel; Hamm, Christian; Jüni, Peter; Valgimigli, Marco; Windecker, Stephan; Onuma, Yoshinobu; Stables, Rod H; Jan van Geuns, Robert; Serruys, Patrick W.
Affiliation
  • Chang CC; Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Doctor Molewaterplein 40, GD Rotterdam, Netherlands.
  • Chichareon P; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Beitou 11217, Taipei, Taiwan.
  • Modolo R; Institute of Clinical Medicine, National Yang Ming University, Beitou 11221, Taipei, Taiwan.
  • Takahashi K; Department of Cardiology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.
  • Kogame N; Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai 90110, Songkhla, Thailand.
  • Tomaniak M; Department of Cardiology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.
  • Gao C; Department of Cardiology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.
  • Royaards KJ; Department of Cardiology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.
  • Cequier A; Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Doctor Molewaterplein 40, GD Rotterdam, Netherlands.
  • Oldroyd K; Cardiology Department, Radboudumc, Comeniuslaan 4 6525 HP, Nijmegen, the Netherlands.
  • Steg PG; Department of Cardiology, Maasstad Hospital, Maasstadweg 21, 3079 DZ, Rotterdam, Netherlands.
  • Hamm C; Department of Cardiology, Bellvitge University Hospital, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Jüni P; West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, UK.
  • Valgimigli M; Cardiology Department, AP-HP, Hospital, Bichat, 75018 Paris, France.
  • Windecker S; Department of Cardiology, Kerckhoff Heart Center, 61231Bad Nauheim, Germany.
  • Onuma Y; Department of Medicine and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, M4P 1A6, Canada.
  • Stables RH; Department of Cardiology, Bern University Hospital, Inselspital, University of Bern, 3010 Bern, Switzerland.
  • Jan van Geuns R; Department of Cardiology, Bern University Hospital, Inselspital, University of Bern, 3010 Bern, Switzerland.
  • Serruys PW; Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Doctor Molewaterplein 40, GD Rotterdam, Netherlands.
Eur Heart J Cardiovasc Pharmacother ; 6(1): 22-30, 2020 01 01.
Article de En | MEDLINE | ID: mdl-31841136

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fragments peptidiques / Maladie des artères coronaires / Thrombose coronarienne / Antithrombiniques / Hirudines / Intervention coronarienne percutanée / Infarctus du myocarde avec sus-décalage du segment ST Type d'étude: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Eur Heart J Cardiovasc Pharmacother Année: 2020 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fragments peptidiques / Maladie des artères coronaires / Thrombose coronarienne / Antithrombiniques / Hirudines / Intervention coronarienne percutanée / Infarctus du myocarde avec sus-décalage du segment ST Type d'étude: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Eur Heart J Cardiovasc Pharmacother Année: 2020 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: Royaume-Uni